Skip to main content
Caplight Logo









Floré

Floré

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://flore.com/

Last Round

Series A

Sep 16, 2020

Total Funding Raised

$12.35M

Company Overview

Floré is a biotechnology company that provides direct-to-consumer gut microbiome testing and personalized probiotic supplements based on whole-genome sequencing analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Subscription Commerce, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

personalized probioticsgut health testmicrobiome testingprobiotic subscriptionwhole genome sequencinggut healthpersonalized nutritiondirect-to-consumerDTCat-home test kitgut testbioinformaticsprebioticsclinical stool analysisMicrobiome EHR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Floré Comparables

Compare Floré with similar companies based on industry and business-model similarity.

Floré comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ombre
85%
Viome Life Sciences, Inc.
84%
Tiny Health
79%

Floré Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2020
SeedOct 24, 2019

Key People

Founding team and executive leadership

Craig Rouskey

Cofounder, CEO

Founding Team

Suneer Sunny Jain

CEO And Founder

Founding Team

Floré Investors

Notable investors and investment history

Floré investors
InvestorRounds
Emerging Technology PartnersSeries A
Danone Manifesto VenturesSeries A
K3 VenturesSeries A
Wolfpack VenturesSeed
Pangaea VenturesSeries A
SOSVSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 71% MoM, reaching 59,000.

  • Jan 21, 2025

    Monthly visitors grew 61% MoM, reaching 51.1K.

Floré Filings

Explore SEC and related filing metadata, where available.

Floré filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Floré's valuation, stock price, and market status.

Is Floré a public or private company?

Floré is a private company.

What is the current stock price of Floré?

Floré is a private company with no public stock price. No recent secondary market data is available.

How much is Floré worth (valuation)?

Valuation information for Floré is not publicly available.

Can I buy Floré stock?

Floré shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Floré's last funding round?

Floré's most recent funding round was Series A on September 16, 2020.

Who are the main investors in Floré?

Key investors in Floré include Pangaea Ventures, SOSV.

Will Floré IPO soon?

No public IPO plans have been announced for Floré.

How can I track Floré secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Floré's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range7
Year Founded2016
Last FundingSep 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?